I’m confused why AI companies are using agents in-house for this type of research instead of partnering externally.
I guess the improvement loop is tighter and they have more control over how discoveries can be used for marketing?
But, in my mind, it begins to feel like they are setting themselves up to be “everything” companies instead of focusing on their core product…
Because their core product is not a long-term sustainable business strategy. Local hardware and models will continue to improve to the point of not needing the hosted solutions. And if you do need a hosted solution, remember that the big cloud providers already offer these solutions, so signing up for OpenAI/Anthropic _and_ AWS/GCP/Azure is not a sound business decision compared to just signing up with 1 of them that offers your cloud infra + GenAI infra. (Which is why the long-term benefits for cloud companies will probably be for the likes of AWS and not the likes of OpenAI).
They'll continue to burn money for marginal model improvements in the next few years all the while having no moat _and_ having Open-Weight / Local models eat their lunch.
The only way for them to stay relevant as a company is to expand beyond simply providing the models.
I'm old enough to remember the arrival of RDBMS, once IBM primed the space with DB2.
There was a pitched battle over features like row-level locking as competitors like Sybase, Ingress and Oracle scrapped it out. New features arrived on a monthly cadence, with immense engineering effort behind them. The winners (Oracle mostly) won a great moat which led to them to where they are today.
The fact that so many AI companies can produce amazing coding tools so quickly shows there is no moat, supporting your theory.
The AI companies moat, if any, is hoarding all the hardware so local solutions are no longer cost-effective.
That is impossible to fund. At some point someone will decide to stop throwing money on the firepit that's the current business model and then hardware prices crash back to earth as 60-70% of the global demand disappears overnight.
This is not really sustainable when there is a constant supply of increasingly powerful and efficient hardware.
The hardware miniaturization gains have finally dried up, though.
I am pretty certain that the current state of the art silicon feature size won't shrink again for at least another decade or two.
It normally takes about a decade to mature a tech which can create a smaller feature size into something commercially viable for mass production scale, and no further improvements have been in the pipeline for that long now.
So it's like the "next piece" indicator while playing Tetris is just blank.
Right: Capital markets know how to efficiently turn dollars into tokens, even if it means tens of billions invested in new DRAM fabs.
It is more of a regulatory capture byproduct to prop up an artificial token driven Ponzi scheme.
There is a serious alternative to NVIDIA "AI" hardware dropping out of China in February 2027. There is no moat, but a whole lot of unpaid debts in the near future.
Popcorn ready =3
Which Chinese alternative is that?
Huawei is upgrading its Ascend 950PR (2.8 times an Nvidia H20 performance.)
https://apnews.com/article/huawei-ai-chips-nvidia-superpod-t...
Take it lightly until the benchmarks drop. ymmv =3
I honestly have no expert knowledge about this stuff. What I say is based only on intuition.
>I don't buy the insurmountable moat of TSMC
Very wise, energy constraints are already feeding the hyper-scale gamblers their own hubris. =3
Reminiscent of tank warfare in WW2. The soviet T-34 was not remarkable in any particular way, but the sheer volumes it was produced in made it a very serious enemy to German tanks. As Stalin said "quantity has a quality all of its own".
I would phrase it slightly differently.
The companies who control the compute resources will ~always control the greatest "amount" of intelligence. They can lease that intelligence out, or they can use it themselves. Currently the "total amount of intelligence" or perhaps "total amount of ability-to-do-stuff" is split between humans and machines at a ratio that means it still makes sense to lease the machine intelligence to the human intelligence - plus there are things that humans are still better at. In maybe 2 more years that will stop being true, due to the availability of more physical compute resources, and far greater model intelligence per unit compute. At that point, the point at which the substantial majority of ability-to-do-stuff is controlled by machine intelligence, then the entities who control all the compute will control all the ability-to-do-stuff, i.e. "the economy."
So I agree that the core product is not long-term sustainable as a product but this is because the whole world will look so different in the near future that the framing of intelligence as a "product" breaks down.
Open-Weight models, of course, are fine and useful, but if you have one million times less compute than your competitor (the lab), then you're not really playing the same game. You can only tackle the problems that they have decided they're not interested in.
Their moat is the tens of GW of power and associated compute.
A chatbot for cancer researchers to talk to is worth single-digit billions at most. Anthropic is already valued at over a trillion dollars, on the premise that they can replace the majority of jobs in most knowledge industries. All the announcements about hacking / math problems / biological science are meant to create the impression that that strategy works and is repeatable across industries.
Cancer research is a lot harder for LLMs than math millennium problems though, because there is no fast feedback loop to iterate on. Even if you have a really good idea based on a solid theoretical insight, doing the experiments using in-vitro/mice/monkeys/humans can take years or even decades. I have no doubt that AI will help find new avenues that boost certain parts of research in these fields, but I don't see a potential for a drastic change until we at the very least give LLMs a direct way to interact with lab equipment and train them using RL on it.
Yes, but initial discovery of molecules and novel mechanisms is massive. That was the last generational change in modern drug research was the movement to high throughput screening, going from the ability to screen 10's of molecules to hundreds of thousands to find 'hits'. Better and more focused models, especially ones trained internally at big pharma companies will accelerate that portion of the pipeline, or increase the hit rate of successful compounds. Several companies are already taking this approach like Novo has been. There are other more early stage companies like Recursion and others that are doing the same thing. They are more tech companies than traditional wet lab companies.
Sorry, yes I agree 100%. I don't agree with their narrative, I was just explaining it. I think it's fraudulent and based on science fiction and will lead to a significant economic crisis.
RL robotics is increasingly something that cannot be avoided, I think.
> ... until we at the very least give LLMs a direct way to interact with lab equipment and train them using RL on it.
Which is exactly what is being done.
https://www.reuters.com/world/anthropic-quietly-sets-up-biol...
Not according to Anthropic:
Automated labs are far more challenging to build and run than most people appreciate. If I wanted to make progress quickly in discovery science, I would find good lab techs before building automated labs.
>A chatbot for cancer researchers to talk to is worth single-digit billions at most
I am disappointed by your lack of Capitalism buff. What you say is true, but what is the untapped fetish market for such a thing?
They do partner externally. This work is fundamental discovery science, rather than industrial research.
the folks who run anthropic grew up reading scifi with crazy awesome biotech. However, when they look at biotech today, it's just depressing. It's incredibly slow, it takes decadfes to prove out new technologies, and they figure with this new tool, they can just point it at problems and have it emit discoveries. If they show a few high-impact discoveries, that makes a case for them to move biotech forward much faster than its current progress.
Also, anthropic has so much capitalization right now that it's simply easiest to invest it in a wide portfolio that includes both internal and external research.
Because the goal is marketing and maxxing the IPO, not real-world results.
Better than doing this, just in case you hadn’t heard: https://www.businessinsider.com/inside-open-ai-influencer-ma...
Yeah I don't think OpenAI are the first company to discover marketing
...which Anthropic is always doing:
(from the third link)https://www.cnbc.com/2026/02/06/google-microsoft-pay-creator...
https://www.reddit.com/r/NYCinfluencersnark/comments/1sn3t9k...
https://aftermath.site/ai-influencer-creator-deals-sponsorsh...
That isn’t actually the point, the point is that the AI companies should be made to see that doing things for society is the only way they get any kudos.
If they want to compete to be seen as the good guy, by all means let them. But it means actually having to be the good guy, in at least some respects.
Indeed, intelligent life on earth confirmed =3
I was actually thinking the other day that it makes perfect sense for AI companies to develop a professional services oriented software development arm. Imagine that you want to develop a training pipeline for "tasteful" programming: you might make a reward metric for that does some obvious stuff (nothing that anyone could easily agree is a bug like a crash, good performance, perhaps minimize LoC), but you really want to also want to also track "bugs" where the feature was discovered to be missing some unspecified nuance that was only discovered through product use, or train on ability to keep a small codebase while also keeping diffs small (essentially, "maintainability") as real new requirements come in.
So then you want a training set full of real product requirements and product evolution, which is something you could get if you offered custom software development, with a lot more control than you'd get trying to do the same by scraping random FOSS projects on github.
Other industries are perhaps similar. If you offer a service directly, you have much more ability to build collection of training data into the process. Want to make the best law bot? Buy a law firm, offer legal services, and integrate extremely deeply into their workflows. If their models turn out to be as good as they hype up, they should be able to scale to be a major player in any endeavor they move into with a relatively small number of staff and develop a strong feedback loop (not that that would be good for the rest of us).
I'm confused of why this is a question. First of all everyone is doing something because it benefits them. You and I included. Second of all as long as it's a real discovery, it will be beneficial to us all eventually (after benefiting Anthropic for sure).
Perhaps you're not on HN long enough, but there have been many posts where someone bemoaned the lack of basic science research by corporations, that IBM and Microsoft were the only a few remaining companies with any science research. Guess what? they do it for their own benefits as well.
What area of basic research are they bemoaning?
Because as I see it, there are a lot of already established labs that could take research like this a lot further with the help of AI instead of just throwing more agents at the problem.
That’s my confusion around this topic. Does the strategy change when you can throw a bonkers amount of compute at the problem with fewer guardrails?
If your core service is getting more expensive to provide and competitors are busy eating your margins, why let someone else taste your secret sauce and only get paid for the tokens, when you can keep the good stuff (bio capability) for yourself, and net both the profit and the fame?
External partners don't trust the AI companies I think to not steal their work and the partner's moat
> I’m confused why AI companies are using agents in-house for this type of research instead of partnering externally.
As an outsider, here is how I explain that behavior:
1. Truly risky models are very useful.
2. Truly risky models should not be released, according to AI safety standards. I think Antrhopic genuinely believes in AI safety. (see: standing up against automated kill chains, no matter the impacts to the company)
3. Truly risky models face regulatory pressures, if released to the public.
This all leads to "let's just do this in-house." I believe that might end up being the answer to every application of AI eventually. It seems unavoidable, and very depressing.
If an amazing drug or other therapeutic falls out of this I bet they would be happy to own it outright.
I wonder what the AI version of Albert Hofman will come up with.
Lands as an active threat. Maybe they're serious about this research or not, but for sure medical companies doing this sort of research will consider upping their AI budget and connecting their labs, etc. to avoid "falling behind".
So, the AI labs benefit either from achieving something they could market or from the peer-pressure imposed to companies in the sectors they get their nose in.
I think the "everything company" vision has become apparent for a while now. Doesn't even have to be sinister - I think Anthropic simply believes on one else can be trusted with this power. Another point of leverage they have is that they can keep their internal models for themselves.
They’re trying to pivot into verticals because being a "dumb model provider" has no real moat any longer.
> “everything” companies instead of focusing on their core product
Aren't all large companies like that? Apple makes hardware, software, platforms, ...
"Everything" is the core product if you are developing AGI
Relevant: "Anthropic quietly sets up biology lab as it ramps AI drug program"
https://www.reuters.com/world/anthropic-quietly-sets-up-biol...
the core product has no moat and they're racing to find the actual product
Because clients don’t know how to use the tools.
I run into this all the time - we have such powerful functionality available to our users, and further we provide the elements that undergird all of it, so it’s totally possible for clients to take the services they buy from us and reconfigure them to make their own tools, better even than the ones we have built, purpose-built for their workflows…
And 9/10 clients will just click on the one thing they know and recognize and are familiar with and comfortable with… and then stop thinking about it.
It’s crazy how much of our job is not only building our product, but interrogating our clients over what they need, so we can demonstrate how our tools solve their problem. The users simply are not interested in figuring it out for themselves.
This is my speculation as well. For the time being, knowing how to use Claude extremely effectively probably beats out industry insider status. And Anthropic can attract whatever expertise it needs to build scrappy research teams in house. I'm guessing this kind of work doesn't need 100+ people, maybe just a dozen highly specialized people.
Given the prestige of the AI labs, the recent explosion of math proofs, the literal millions they can throw around, it seems very likely they can attract then fund small research projects across a broad range of science. And like startup math, it only takes one or two ground breaking results from a hundred attempts to pay back in the PR/hype.
[dead]